TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive Mammography Controversy Continues: Task Force Alters Web Site To Clarify Recommendation On Mammography December 4, 2009
TCL Archive Oxaliplatin Regimens Extend Survival Of Advanced Colorectal Cancer, Study Finds June 27, 2003
